Related Experiment Video
Updated: Feb 14, 2026
09:29
Author Spotlight: Hypothalamic Neural Mechanism Insights
Published on: August 4, 2023
4.8K
Targeted Orexin and Hypothalamic Neuropeptides for Migraine
Lauren C Strother1, Anan Srikiatkhachorn2, Weera Supronsinchai3
1Headache Group, Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. lauren.strother@kcl.ac.uk.
Summary
The hypothalamus and its neuropeptides are central to migraine pathophysiology. Further research into these systems may lead to novel migraine prevention therapies.
Area of Science:
- Neuroscience
- Endocrinology
- Pain Research
Background:
- The hypothalamus regulates homeostatic mechanisms and trigeminal nociception, suggesting a key role in migraine.
- Hypothalamic neuropeptide systems, including orexins, oxytocin, neuropeptide Y, and pituitary adenylate cyclase activating protein (PACAP), are implicated in migraine pathophysiology.
Purpose of the Study:
- To review the role of key hypothalamic neuropeptide systems in migraine pathophysiology.
- To explore preclinical and clinical evidence for therapeutic targeting of these systems.
Main Methods:
- Review of preclinical studies on hypothalamic neuropeptides and their role in migraine.
- Analysis of clinical trial data for therapeutic agents targeting orexin and oxytocin systems.
- Overview of ongoing clinical trials for PACAP and future directions for neuropeptide Y.
Main Results:
- Preclinical studies support the involvement of orexins, oxytocin, neuropeptide Y, and PACAP in migraine.
- Clinical trials of dual orexin receptor antagonists and intranasal oxytocin have shown limited efficacy but suggest potential.
- Early clinical trials for PACAP are promising, while neuropeptide Y has yet to be clinically investigated.
Conclusions:
- The hypothalamus and its neuropeptides play a significant role in migraine.
- Targeting these systems offers potential for developing new migraine therapies.
- Further research is needed to optimize therapeutic strategies for migraine prevention.
Related Concept Videos
01:37Hypothalamic-Pituitary Axis
66.7K
The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.
66.7K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
01:26Targets for Drug Action: Overview
10.6K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.6K
01:22Target Cell Response to Hormones
5.8K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.8K
01:29Pharmacogenomics: Identification of New Drug Targets
8
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
8
01:24Modified-Release Drug Delivery Systems: Site-Targeted
18
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
18